ESR1 and breast carcinoma: Despite these advancements in cancer research and improved treatment outcomes, breast cancer remains the second leading cause of cancer‐related deaths among women worldwide, following lung cancer, according to 2023 statistics.[1] Approximately 80% of breast cancer cases are estrogen receptor‐positive (ER+) luminal types.